These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Effect of dietary protein on the renal response to fenoldopam in diabetic rats. Wang YX; Brooks DP Eur J Pharmacol; 1993 Oct; 248(3):217-21. PubMed ID: 7904943 [TBL] [Abstract][Full Text] [Related]
47. Intravenous fenoldopam versus sodium nitroprusside in patients with severe hypertension. Reisin E; Huth MM; Nguyen BP; Weed SG; Gonzalez FM Hypertension; 1990 Feb; 15(2 Suppl):I59-62. PubMed ID: 1967592 [TBL] [Abstract][Full Text] [Related]
48. Comparative effects of fenoldopam mesylate and nitroprusside on left ventricular performance in severe systemic hypertension. Hackman BB; Griffin B; Mills M; Ramanathan KB Am J Cardiol; 1992 Apr; 69(9):918-22. PubMed ID: 1347965 [TBL] [Abstract][Full Text] [Related]
49. Fenoldopam is a partial agonist at dopamine-1 (DA1) receptors in LLC-PK1 cells. Grenader A; Healy DP J Pharmacol Exp Ther; 1991 Jul; 258(1):193-8. PubMed ID: 1677038 [TBL] [Abstract][Full Text] [Related]
50. Evidence from functional and autoradiographic studies for the presence of tubular dopamine-1 receptors and their involvement in the renal effects of fenoldopam. Hedge SS; Ricci A; Amenta F; Lokhandwala MF J Pharmacol Exp Ther; 1989 Dec; 251(3):1237-45. PubMed ID: 2574743 [TBL] [Abstract][Full Text] [Related]
51. Increase in plasma renin activity evoked by fenoldopam in dogs is directly mediated by dopamine1 receptor stimulation. Montier F; Katchadourian P; Pratz J; Cavero I J Cardiovasc Pharmacol; 1989 May; 13(5):739-47. PubMed ID: 2472522 [TBL] [Abstract][Full Text] [Related]
52. Antagonism of a specific dopaminergic receptor agonist with metoclopramide in horses. Eades SC; Moore JN Am J Vet Res; 1993 Jan; 54(1):122-5. PubMed ID: 8093992 [TBL] [Abstract][Full Text] [Related]
53. Effects of fenoldopam on cecal blood flow and mechanical activity in horses. Clark ES; Moore JN Am J Vet Res; 1989 Nov; 50(11):1926-30. PubMed ID: 2575878 [TBL] [Abstract][Full Text] [Related]
54. Effect of fenoldopam on preconstricted isolated salt-perfused rat lungs. Polak MJ; Knight ME; Gause GE; Bucciarelli RL; Drummond W J Appl Physiol (1985); 1989 Sep; 67(3):1076-80. PubMed ID: 2571605 [TBL] [Abstract][Full Text] [Related]
55. Effects of fenoldopam on intracranial pressure and hemodynamic variables at normal and elevated intracranial pressure in anesthetized pigs. Hennes HJ; Jantzen JP J Neurosurg Anesthesiol; 1994 Jul; 6(3):175-81. PubMed ID: 7915922 [TBL] [Abstract][Full Text] [Related]
57. Comparisons of the depressor, inotropic and renal effects of milrinone and CI-930 to different pure vasodilators and diuretics in conscious instrumented dogs. Lee KC; Clas DM; Gorczyca WP; Silver PJ; Ezrin AM Drugs Exp Clin Res; 1991; 17(7):323-36. PubMed ID: 1686584 [TBL] [Abstract][Full Text] [Related]
58. Hemodynamic, renal, and neurohumoral effects of a selective oral DA1 receptor agonist (fenoldopam) in patients with congestive heart failure. Francis GS; Wilson BC; Rector TS Am Heart J; 1988 Aug; 116(2 Pt 1):473-9. PubMed ID: 2899970 [TBL] [Abstract][Full Text] [Related]
59. Assessment of hemodynamic tolerance from a 24-hour intravenous infusion of fenoldopam mesylate in congestive heart failure. Munger MA; Benotti JR; Green JA; Jarvis RC; Nara AR; McCue JE; Pospisil RA; Kasmer RJ Am J Cardiol; 1990 Jan; 65(3):206-10. PubMed ID: 1967511 [TBL] [Abstract][Full Text] [Related]
60. SK&F 87516, a close analog of fenoldopam, is a partial agonist at dopamine-1 and alpha-2 receptors and produces stimulation of 5-hydroxytryptamine-2 receptors in the cardiovascular system of the rat. Le Monnier de Gouville AC; Lawson K; Thiry C; Cavero I J Pharmacol Exp Ther; 1991 Mar; 256(3):1049-56. PubMed ID: 1672375 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]